S
Stemora develops novel cell-based therapies focused on regenerating cartilage for patients suffering from osteoarthritis. The company leverages stem cell innovation to create treatment options aimed at restoring joint mobility. Their work seeks to redefine the standard of care for osteoarthritis management.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Stemorabio develops novel cell and gene therapies targeting complex diseases with high unmet medical need. The company focuses on proprietary induced pluripotent stem cell (iPSC) technology to generate functional, disease-relevant cell products for therapeutic use. Their pipeline aims to provide scalable and precise treatments by leveraging advanced regenerative medicine platforms.